Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Profesionales de la salud / Universidad de OncoLink / MD2B: Cursos Esenciales /
Amy Feldman, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 23 de julio del 2006
Wilms tumor, also known as "nephroblastoma", is a solid tumor that arises from immature kidney cells. Wilms tumor is the fourth most common type of pediatric cancer, and is the most common type of kidney cancer to occur in children. Approximately 500 new cases are diagnosed each year. Wilms tumor most frequently occurs around the age of 3, and is rarely seen after 8 years of age. It usually affects only one kidney (unilateral), but in 5% of cases can affect both kidneys (bilateral). The overall five-year survival rate for children with Wilms' tumor is more than 90%. Prognosis depends on stage (how far the cancer has spread), histopathologic features (what the cancer cells look like under the microscope), patient age, and tumor size.
Most Wilms tumors are found only after the tumor has become quite large because the tumors can grow for some time without causing pain or making the child appear unhealthy. Luckily however, the tumors are usually discovered before they have metastasized (spread to other organs). Most commonly, the tumor is discovered because the child's abdomen begins to swell. Often parents appreciate a hard mass in the child's belly while they are bathing or dressing their child. The tumor is not usually painful to the child. Other less common symptoms of Wilms tumor include abdominal pain, fever, hematuria (blood in the urine), nausea, vomiting, weight change, change in bowel movements, or high blood pressure observed at the pediatrician's office (due to elevated levels of a substance in the blood called renin).
The child's physician will perform a physical examination, schedule imaging tests, and order laboratory tests to help determine if the child has Wilms tumor and to aid in developing the appropriate treatment plan.
Based on physical examination, imaging studies, laboratory tests, and possibly biopsy (tissue sample) the doctor will stage the tumor according to the following categories:
Stage 1: tumor confined to only the kidney and can be completely removed by surgery
Stage 2: tumor extends beyond the kidney but can be completely removed by surgery
Stage 3: cancer has spread slightly beyond the kidney (but not outside of the abdomen and pelvis) and can not be completely removed by surgery
Stage 4: cancer has spread outside the abdomen and pelvis to other organs such as the lungs, liver, bone, or brain
Stage 5: cancer in both kidneys
Age of the patient, size of the tumor, lymph node involvement and metastases at time of diagnosis, and appearance of the cancer cells are all important prognostic factors in determining survival.
Treatment of Wilms tumor involves combinations of surgery, chemotherapy, and possibly radiation. Due to advances in the treatment of Wilms tumor, the overall success rate in curing this type of cancer is now around 90%.
Surgical removal is the primary method for achieving local control of the cancer. A surgeon will perform a "nephrectomy" removing part of the kidney, the whole kidney, or the kidney plus surrounding tissue depending on the location and spread of the tumor at time of diagnosis.
Chemotherapy is a systemic treatment for Wilms tumor. Chemotherapy is taken orally or IV. It travels through the bloodstream and goes throughout the entire body to kill cancer that has spread beyond the kidney. Side effects of chemotherapy include nausea and vomiting, mouth sores, change in bowel habits, loss of hair, increased risk of infection, fatigue, and bruising.
Radiation uses high-energy rays to kill cancer cells. Radiation is used in the more advanced stages of Wilms tumor. Side effects of radiation include nausea, diarrhea, fatigue, and skin changes.
In a small number of cases, Wilms tumor arises as part of a congenital malformation syndrome. In the WAGR syndrome which results from a mutation at chromosome 11p, children have Wilms tumor, aniridia (absence of the iris of the eye), genital-urinary malformations, and mental retardation. In Denys-Drash Syndrome which also results from a mutation at 11p, children suffer from the combination of Wilms tumor, renal (kidney) disease, and pseudo-hermpahroditism ( genitalia are of one sex, but some physical characteristics of the other sex are present ). In Beckwith-Wiedemann Syndrome, children have macroglossia (a large tongue), omphalocele (abdominal organs outside of the body), Wilms tumor, and visceromegaly (large organs). Wilms tumor has also been described in association with Bloom Syndrome, Fanconi anemia, and Li Fraumeni syndrome.
Bernstein L, Linet M, Smith MA, et al. "Renal Tumors." In Ries LAG, Smith MA, Gurney JG, eds. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program . Bethesda, MD: NIH Publications. No 99-4649, 1999: pp 79-90.
Dome J, Perlman E, Ritchey M, Coppes M, Grundy P, Kalapurakal J. "Renal Tumors."
In: Principles and Practice of Pediatric Oncology Fifth Edition, Pizzo, PA, Poplack, DG (Eds), Lippincott Williams Wilkins, Philadelphia 2006. pp 905-932.
Jayabase S, Iqbal K, Newman L, et al. "Hypercalcemia in childhood renal tumors." Cancer. 1988; 61: 788-791.
"Wilms Tumor." National Cancer Institute Web Site.
Ms. Bruning talks about working in development for a cancer center and how this translates to hope in cancer care. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

